Cargando…

Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration

BACKGROUND: Nanostructured lipid carriers (NLCs), composed of solid and liquid lipids, and surfactants are potentially good colloidal drug carriers. Thymoquinone is the main bioactive compound of Nigella sativa. In this study, the preparation, gastroprotective effects, and pharmacokinetic (PK) prope...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelwahab, Siddig Ibrahim, Sheikh, Bassem Yousef, Taha, Manal Mohamed Elhassan, How, Chee Wun, Abdullah, Rasedee, Yagoub, Umar, El-Sunousi, Rashad, Eid, Eltayeb EM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692342/
https://www.ncbi.nlm.nih.gov/pubmed/23818776
http://dx.doi.org/10.2147/IJN.S44108
_version_ 1782274601055682560
author Abdelwahab, Siddig Ibrahim
Sheikh, Bassem Yousef
Taha, Manal Mohamed Elhassan
How, Chee Wun
Abdullah, Rasedee
Yagoub, Umar
El-Sunousi, Rashad
Eid, Eltayeb EM
author_facet Abdelwahab, Siddig Ibrahim
Sheikh, Bassem Yousef
Taha, Manal Mohamed Elhassan
How, Chee Wun
Abdullah, Rasedee
Yagoub, Umar
El-Sunousi, Rashad
Eid, Eltayeb EM
author_sort Abdelwahab, Siddig Ibrahim
collection PubMed
description BACKGROUND: Nanostructured lipid carriers (NLCs), composed of solid and liquid lipids, and surfactants are potentially good colloidal drug carriers. Thymoquinone is the main bioactive compound of Nigella sativa. In this study, the preparation, gastroprotective effects, and pharmacokinetic (PK) properties of thymoquinone (TQ)-loaded NLCs (TQNLCs) were evaluated. METHOD: TQNLCs were prepared using hydrogenated palm oil (Softisan® 154), olive oil, and phosphatidylcholine for the lipid phase and sorbitol, polysorbate 80, thimerosal, and double distilled water for the liquid lipid material. A morphological assessment of TQNLCs was performed using various methods. Analysis of the ulcer index, hydrogen concentration, mucus content, and biochemical and histochemical studies confirmed that the loading of TQ into the NLCs significantly improved the gastroprotective activity of this natural compound against the formation of ethanol-induced ulcers. The safety of TQNLC was tested on WRL68 liver normal cells with cisplatin as a positive control. RESULTS: The average diameter of the TQNLCs was 75 ± 2.4 nm. The particles had negative zeta potential values of −31 ± 0.1 mV and a single melting peak of 55.85°C. Immunohistochemical methods revealed that TQNLCs inhibited the formation of ethanol-induced ulcers through the modulation of heat shock protein-70 (Hsp70). Acute hepatotoxic effects of the TQNLCs were not observed in rats or normal human liver cells (WRL-68). After validation, PK studies in rabbits showed that the PK properties of TQ were improved and indicated that the drug behaves linearly. The T(max), C(max), and elimination half-life of TQ were found to be 3.96 ± 0.19 hours, 4811.33 ± 55.52 ng/mL, and 4.4933 ± 0.015 hours, respectively, indicating that TQ is suitable for extravascular administration. CONCLUSION: NLCs could be a promising vehicle for the oral delivery of TQ and improve its gastroprotective properties.
format Online
Article
Text
id pubmed-3692342
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-36923422013-07-01 Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration Abdelwahab, Siddig Ibrahim Sheikh, Bassem Yousef Taha, Manal Mohamed Elhassan How, Chee Wun Abdullah, Rasedee Yagoub, Umar El-Sunousi, Rashad Eid, Eltayeb EM Int J Nanomedicine Original Research BACKGROUND: Nanostructured lipid carriers (NLCs), composed of solid and liquid lipids, and surfactants are potentially good colloidal drug carriers. Thymoquinone is the main bioactive compound of Nigella sativa. In this study, the preparation, gastroprotective effects, and pharmacokinetic (PK) properties of thymoquinone (TQ)-loaded NLCs (TQNLCs) were evaluated. METHOD: TQNLCs were prepared using hydrogenated palm oil (Softisan® 154), olive oil, and phosphatidylcholine for the lipid phase and sorbitol, polysorbate 80, thimerosal, and double distilled water for the liquid lipid material. A morphological assessment of TQNLCs was performed using various methods. Analysis of the ulcer index, hydrogen concentration, mucus content, and biochemical and histochemical studies confirmed that the loading of TQ into the NLCs significantly improved the gastroprotective activity of this natural compound against the formation of ethanol-induced ulcers. The safety of TQNLC was tested on WRL68 liver normal cells with cisplatin as a positive control. RESULTS: The average diameter of the TQNLCs was 75 ± 2.4 nm. The particles had negative zeta potential values of −31 ± 0.1 mV and a single melting peak of 55.85°C. Immunohistochemical methods revealed that TQNLCs inhibited the formation of ethanol-induced ulcers through the modulation of heat shock protein-70 (Hsp70). Acute hepatotoxic effects of the TQNLCs were not observed in rats or normal human liver cells (WRL-68). After validation, PK studies in rabbits showed that the PK properties of TQ were improved and indicated that the drug behaves linearly. The T(max), C(max), and elimination half-life of TQ were found to be 3.96 ± 0.19 hours, 4811.33 ± 55.52 ng/mL, and 4.4933 ± 0.015 hours, respectively, indicating that TQ is suitable for extravascular administration. CONCLUSION: NLCs could be a promising vehicle for the oral delivery of TQ and improve its gastroprotective properties. Dove Medical Press 2013 2013-06-17 /pmc/articles/PMC3692342/ /pubmed/23818776 http://dx.doi.org/10.2147/IJN.S44108 Text en © Abdelwahab et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Abdelwahab, Siddig Ibrahim
Sheikh, Bassem Yousef
Taha, Manal Mohamed Elhassan
How, Chee Wun
Abdullah, Rasedee
Yagoub, Umar
El-Sunousi, Rashad
Eid, Eltayeb EM
Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration
title Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration
title_full Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration
title_fullStr Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration
title_full_unstemmed Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration
title_short Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration
title_sort thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692342/
https://www.ncbi.nlm.nih.gov/pubmed/23818776
http://dx.doi.org/10.2147/IJN.S44108
work_keys_str_mv AT abdelwahabsiddigibrahim thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration
AT sheikhbassemyousef thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration
AT tahamanalmohamedelhassan thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration
AT howcheewun thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration
AT abdullahrasedee thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration
AT yagoubumar thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration
AT elsunousirashad thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration
AT eideltayebem thymoquinoneloadednanostructuredlipidcarrierspreparationgastroprotectioninvitrotoxicityandpharmacokineticpropertiesafterextravascularadministration